Spiolto Respimat
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Spiolto Respimat, covering 2018-10-15 to 2024-03-15. Get the full timeline:
Most recent: Clinical Trial Update: Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)